522 related articles for article (PubMed ID: 16172107)
1. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
[TBL] [Abstract][Full Text] [Related]
4. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
Gordien AY; Gray AI; Franzblau SG; Seidel V
J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141
[TBL] [Abstract][Full Text] [Related]
7. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
8. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
12. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Jia L; Tomaszewski JE; Hanrahan C; Coward L; Noker P; Gorman G; Nikonenko B; Protopopova M
Br J Pharmacol; 2005 Jan; 144(1):80-7. PubMed ID: 15644871
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
15. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity.
Zhang X; Hu Y; Chen S; Luo R; Yue J; Zhang Y; Duan W; Wang H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6074-7. PubMed ID: 19796945
[TBL] [Abstract][Full Text] [Related]
18. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
19. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
Sriram D; Yogeeswari P; Devakaram RV
Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]